Provided by Tiger Trade Technology Pte. Ltd.

InspireMD

0.6678
-0.0259-3.74%
Post-market: 0.68000.0122+1.83%19:02 EDT
Volume:178.04K
Turnover:119.33K
Market Cap:31.05M
PE:-1.03
High:0.7100
Open:0.7048
Low:0.6101
Close:0.6938
52wk High:2.57
52wk Low:0.6000
Shares:46.49M
Float Shares:34.07M
Volume Ratio:2.75
T/O Rate:0.52%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.6464
EPS(LYR):-0.7584
ROE:-202.81%
ROA:-85.85%
PB:0.99
PE(LYR):-0.88

Loading ...

InspireMD director Gary S. Roubin acquires $106,200 in common shares

Reuters
·
May 09

InspireMD Q1 FY26 net loss widens 22.6% to $13.69 million; revenue more than doubles to $3.4 million

Reuters
·
May 07

InspireMD to Participate in Upcoming Bank of America Securities 2026 Global Healthcare Conference

GlobeNewswire
·
May 07

InspireMD Price Target Cut to $3.00/Share From $4.00 by Piper Sandler

Dow Jones
·
May 06

InspireMD Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

InspireMD Q1 revenue jumps 122%, beats estimates on product demand

Reuters
·
May 05

InspireMD Q1 FY26 net loss narrows to $13.7 million; revenue more than doubles to $3.4 million

Reuters
·
May 05

InspireMD Q1 EPS $(0.16) Beats $(0.19) Estimate, Sales $3.398M Beat $2.698M Estimate

Benzinga Earnings
·
May 05

InspireMD Inc - on Track for FDA Approval of Cguard Prime 80 Cm for Tcar in H2 2026

THOMSON REUTERS
·
May 05

InspireMD price target lowered to $4 from $5 at Lake Street

TIPRANKS
·
May 04

InspireMD initiates voluntary U.S. recall of CGuard Prime 135 cm system

TIPRANKS
·
May 04

Piper Sandler Remains a Buy on InspireMD (NSPR)

TIPRANKS
·
May 04

InspireMD Inc expected to post a loss of 18 cents a share - Earnings Preview

Reuters
·
May 02

InspireMD Recalls CGuard Prime Delivery System, Pauses U.S. Launch

TIPRANKS
·
May 02

InspireMD Withdraws Guidance, Recalls CGuard Prime

Dow Jones
·
May 02

InspireMD announces FDA approval of IDE application for CGUARDIANS III study

TIPRANKS
·
May 02

InspireMD Inc - Withdraws Prior Full Year 2026 Revenue Guidance

THOMSON REUTERS
·
May 02

InspireMD Inc - Recall Follows Technical Performance of Cguard Prime 135 Cm Not Meeting Expectations

THOMSON REUTERS
·
May 02

InspireMD Inc - FDA Approval, U.S. Availability of Original Cguard Delivery System Anticipated in Q3 2026

THOMSON REUTERS
·
May 02

InspireMD Inc - Recall Does Not Include Cguard Stent Implant

THOMSON REUTERS
·
May 02